These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17786279)

  • 1. Head and neck cancer triggers the internalization of TLR3 in natural killer cells.
    Xie L; Pries R; Kesselring R; Wulff S; Wollenberg B
    Int J Mol Med; 2007 Oct; 20(4):493-9. PubMed ID: 17786279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
    Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
    Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
    Pries R; Hogrefe L; Xie L; Frenzel H; Brocks C; Ditz C; Wollenberg B
    Int J Mol Med; 2008 Feb; 21(2):209-15. PubMed ID: 18204787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
    Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
    J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages.
    Wulff S; Pries R; Börngen K; Trenkle T; Wollenberg B
    Anticancer Res; 2009 Aug; 29(8):3053-7. PubMed ID: 19661315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver.
    Wang J; Xu J; Zhang W; Wei H; Tian Z
    Cell Mol Immunol; 2005 Dec; 2(6):449-53. PubMed ID: 16426495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption.
    Lin Y; Zeng Y; Zeng S; Wang T
    Fertil Steril; 2006 Apr; 85 Suppl 1():1125-9. PubMed ID: 16616084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
    Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A
    Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
    Kumazawa H; Minamino M; Yukawa N; Hess M
    Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
    Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
    Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stroma enhances activation of TLR3-triggered NK cells through fibronectin.
    Xia S; Guo Z; Yao Y; Xu X; Yi H; Xia D; Cao X
    Mol Immunol; 2008 May; 45(10):2831-8. PubMed ID: 18384880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3 agonist enhances IFN-gamma and TNF-alpha production by murine uterine NK cells.
    Zhang J; Sun R; Wei H; Wu D; Tian Z
    Int Immunopharmacol; 2007 May; 7(5):588-96. PubMed ID: 17386406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q; Wei H; Tian Z
    BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally active toll-like receptor 3 on human primary and metastatic cancer cells.
    Matijevic T; Marjanovic M; Pavelic J
    Scand J Immunol; 2009 Jul; 70(1):18-24. PubMed ID: 19522763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.